Searched for
AZAD RANBAXY
Aster Healthcare to invest Rs 1,000 cr in five new hospitalsThe hospital chain, which began in Dubai as a drug distributor in 1987, will add one more facility each in Hyderabad, Bangalore and Chennai...- West Bengal’s education group with focus on specialised MBA programsThe institute has been propagating the importance of higher studies for the past 14 years.
- Lapses by few drugmakers clouded good manufacturing practices by others: USFDA chiefThe US drug regulator has in 2013 hauled up leading India-based firms like Ranbaxy for failure to comply with good manufacturing practices.
- India to discuss 'informally' 'disproportionate' action against Indian pharmaceutical firms with USAttention was drawn to disproportionate penalties imposed in some cases, without specifically referring to $500-million fine slapped on Ran...
- Affordable drugs don't mean spurious: Ghulam Nabi Azad tells USGhulam Nabi Azad did some plainspeak with the head of US drug regulator, asserting that Indian drugs should not be treated as spurious.
- FDA chief Margaret Hamburg's visit may soothe jittery nervesIn the last few months, there's been a spike in "violations" at Indian drug factories, according to data from FDA's Centre for Drug Evaluat...
- FDI in Pharma: PM vetoes DIPP, clears decks for Mylan's $1.6 bn takeover of Agila SpecialtiesThe decks have been cleared for US-based Mylan Inc's $1.6-billion takeover of Agila Specialties, sending a positive signal to foreign inves...
- Ten stocks in focus in Wednesday morning tradeIndian markets are likely to trade in a range. Here is a list of ten stocks which are likely to remain in focus in morning trade.
- Ranbaxy facilities under review: Gulam Nabi AzadRanbaxy facilities in India are being reviewed after its US arm admitted to manufacturing certain drugs not in conformity with good practic...
- No decision on Ranbaxy probe yet: Health MinistryThe Health min is still taking stock of the Ranbaxy Labs' US-related problems, but has not yet decided to launch any probe on the matter
- Pharma industry unhappy with Govt decision on FDIPharmaceutical industry today criticised the government's decision to make it mandatory for all foreign investments in existing domestic ph...
- FIPB to approve foreign investments in pharma sectorThe nodal body responsible for approving foreign investments that require government approval would continue to clear foreign acquisitions ...
- India develops a synthetic anti-malaria drug as an alternative ArtemisininIndia has developed a powerful new malaria drug - an alternative to the global drug of choice Artemisinin - that promises to be a major boo...
- 100% foreign direct investment regime in pharmaceutical sectorA high-level inter-ministerial group chaired by the prime minister has decided to continue with the 100% foreign direct investment regime i...
- FDI in pharmaceutical to pass through filterThe government on Monday decided to put a filter into foreign direct investment in the pharmaceutical sector.
- Govt mulls tighter pharma FDI normsWorried over the spate of takeover of Indian pharmaceutical companies by multinational firms, the government has set up a panel to study th...
- Hetero bags deal for 10 m TamifluHetero Drugs has pipped Ranbaxy Laboratories, Cipla, Natco Pharma, Strides Arcolabs and Roche India to bag half the government order to sup...
- Makers of Tamiflu version see share prices surgeShare price of drug companies Ranbaxy, Natco and Strides Acrolabs, that make low-priced versions of anti-flu medicine Tamiflu, surged on Tu...
- Cipla, Ranbaxy in fray to bag govt contract for TamifluDrugmakers Cipla, Ranbaxy, Hetero and Natco are expected to be in the fray to bag the government's contract to buy 20 million low cost anti...
- Govt to import 2 cr more pills to treat H1N1With about 70% of its stock used up, the government will now procure two crore more pills of oseltamivir—the generic version of Swiss firm ...
Load More
